Top Markets
#1 Velas Velas +367.72%
#2 Gravity Gravity +48.67%
#3 Galxe Galxe +41.03%
#4 Audiera Audiera +35.08%
#5 Infinity Ground Infinity Ground +30.54%
#6 Nosana Nosana +30.00%
#7 Babylon Babylon +21.78%
#8 Aria.AI Aria.AI +21.37%
#9 Wiki Cat Wiki Cat +21.18%
#10 Fetch.ai Fetch.ai +20.36%
Coin of the day
Velas Velas
Settings
Language
ENGLISH
Currency
USD
Theme
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rank in Stocks #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Share Price
$38.05
Market Cap
$169.07B
Change (1 day)
0.22%
Change (1 year)
-50.38%
Country
DK
Trade Novo Nordisk A/S (NVO)

Category

Healthcare
Market Capitalization
Revenue
more
Earnings
Price History
P/E Ratio
P/S Ratio
P/B Ratio
Operating Margin
EPS
Stock Splits
Dividends
Dividend Yield
Shares Outstanding
Stock price history for Novo Nordisk A/S (NVO)
Highest end of day price: $38.27 on 2026-03-01

Lowest end of day price: $28.10 on 2007-07-01
Stock price history of Novo Nordisk A/S from 2007 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 17.69%
2025 -51.54%
2024 1.70%
2023 -23.31%
2022 17.33%
2021 57.90%
2020 22.89%
2019 26.29%
2018 -13.92%
2017 49.77%
2016 -37.97%
2015 26.27%
2014 24.70%
2013 10.84%
2012 43.58%
2011 6.03%
2010 -4.61%
2009 14.74%
2008 -41.68%
2007 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $466.99 -7.48%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $756.54 13.45%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $300.57 53.64%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $99.21 -36.97%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $707.92 17.02%
NL